Page last updated: 2024-08-24

cidofovir anhydrous and Obesity

cidofovir anhydrous has been researched along with Obesity in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bouscarat, F; Boutolleau, D; Bucau, M; Burrel, S; Fidouh, N; Ghosn, J; Hachon, L; Joly, V; Khellaf, L; Lariven, S; Le Pluart, D; Thy, M1
Dhurandhar, NV; Heydari, AR; Holland, TC; Krishnan, B; Rathod, M; Vangipuram, SD1

Other Studies

2 other study(ies) available for cidofovir anhydrous and Obesity

ArticleYear
Novel mutations in antiviral multiresistant HSV-2 genital lesion: A case report.
    Journal of medical virology, 2022, Volume: 94, Issue:12

    Topics: Acyclovir; Antiviral Agents; Cidofovir; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Genitalia; Herpes Simplex; Herpesvirus 2, Human; Humans; Imiquimod; Mutation; Obesity; Thymidine Kinase; Valacyclovir

2022
Viral mRNA expression but not DNA replication is required for lipogenic effect of human adenovirus Ad-36 in preadipocytes.
    International journal of obesity (2005), 2007, Volume: 31, Issue:1

    Topics: 3T3-L1 Cells; Adenovirus E1A Proteins; Adenovirus E4 Proteins; Adenoviruses, Human; Adipocytes; Adipogenesis; Animals; Antiviral Agents; CCAAT-Enhancer-Binding Protein-beta; Cidofovir; Cytosine; DNA Replication; DNA, Viral; Gene Expression; Genes, Viral; Humans; Mice; Obesity; Organophosphonates; RNA, Viral

2007